cdmo.directory
← Compare landing

BioVectra vs FUJIFILM Biotechnologies

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryBioVectraFUJIFILM Biotechnologies
SummaryNorth American CDMO specializing in clinical-to-commercial biologics, small molecules, HPAPIs, and bioreagents with 50+ years of microbial fermentation and complex chemistry expertise across cGMP facilities in Canada.CDMO partner offering end-to-end biologics development and manufacturing from pre-clinical through commercialization, with expertise in cell culture, microbial fermentation, cell and gene therapy, and cGMP manufacturing across US and European facilities.
Services
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Biologics Development & Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Microbial Fermentation
  • mRNA Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Microbial Fermentation
  • Viral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Vaccine Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Biologics (Other)
  • Oligonucleotide
  • mRNA
  • Gene Therapy
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
Development capabilities
  • Analytical method development
  • Formulation development
  • Cell line development
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Max bioreactor: Large commercial (≤10,000 L)
  • Expression: Mammalian
  • Expression: Microbial
  • Expression: Viral Vector
  • Expression: Cell-Free
  • Stainless Steel
  • Max chemical: Commercial (>100 kg / tonne)
  • HPAPI
  • Flow Chemistry
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
  • Expression: Microbial
  • Expression: Viral Vector
  • Expression: Cell-Free
  • Single-Use / Disposable
  • Stainless Steel
Locations
  • Headquarters, Charlottetown, Prince Edward Island, Canada
  • Research & Development, Charlottetown, Prince Edward Island, Canada
  • New API Facility, Charlottetown, Prince Edward Island, Canada
  • Dedicated Facility, Charlottetown, Prince Edward Island, Canada
  • Large Scale Biomanufacturing Facility, Windsor, Nova Scotia, Canada
  • Research & Development, Prince Edward Island, PE, Canada
  • Headquarters, Prince Edward Island, PE, Canada
  • New API Facility, Prince Edward Island, PE, Canada
  • Dedicated Natural Extraction Facility, Prince Edward Island, PE, Canada
  • Headquarters, Cambridge, MA, USA
  • College Station, College Station, TX, USA
  • Holly Springs, Holly Springs, NC, USA
  • Research Triangle Park, Research Triangle Park, NC, USA
  • Thousand Oaks, Thousand Oaks, CA, USA
  • Billingham, Billingham, UK
  • Wilton, Wilton, UK
  • Hillerød, Hillerød, Denmark
  • Japan, Japan
  • US Facility, United States
  • United States, United States
  • Headquarters
  • Commercial-scale manufacturing, Hillerød, Denmark
CertificationsData not yet provided.Data not yet provided.

Find similar companies

BioVectra alternatives · FUJIFILM Biotechnologies alternatives

Markdown mirror: /compare/biovectra/fujifilm-biotechnologies.md